Civitas Solutions ROE 2012-2018 | CIVI

Current and historical return on equity (ROE) values for Civitas Solutions (CIVI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Civitas Solutions ROE for the three months ending June 30, 2018 was 31.01%.
Civitas Solutions ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-06-30 $0.01B $0.17B 3.55%
2018-03-31 $0.00B $0.17B 1.77%
2017-12-31 $0.01B $0.18B 5.95%
2017-09-30 $0.01B $0.16B 3.07%
2017-06-30 $0.02B $0.17B 11.99%
2017-03-31 $0.02B $0.16B 11.28%
2016-12-31 $0.02B $0.15B 13.17%
2016-09-30 $0.01B $0.15B 6.52%
2016-06-30 $0.01B $0.14B 7.59%
2016-03-31 $0.01B $0.14B 4.74%
2015-12-31 $0.00B $0.13B 0.82%
2015-09-30 $0.00B $0.12B 3.40%
2015-06-30 $-0.01B $0.12B -5.15%
2015-03-31 $-0.01B $0.12B -8.09%
2014-12-31 $-0.02B $0.11B -36.68%
2014-09-30 $-0.02B $0.12B -79.31%
2014-06-30 $-0.02B $0.00B 144.68%
2014-03-31 $-0.02B $0.00B 88.31%
2013-12-31 $-0.01B $0.00B 25.97%
Sector Industry Market Cap Revenue
Medical Medical Services $0.472B $1.475B
Civitas Solutions, Inc. is a national network of local health and human services. It operates as a provider of an array of community-based services to adults and children with intellectual and developmental disabilities, brain and spinal cord injuries and other catastrophic injuries and illnesses, and to youth with emotional, behavioral and medically complex challenges, as well as their families. The Company serves governmental agencies, non-public payors, and not-for-profit organizations. Civitas Solutions, Inc. is based in Boston, Massachusetts.
Stock Name Country Market Cap PE Ratio
Express Scripts Holding (ESRX) United States $54.367B 11.24
ICON (ICLR) Ireland $7.475B 23.43
PRA Health Sciences (PRAH) United States $6.757B 27.59
Charles River Laboratories (CRL) United States $6.195B 21.72
Premier (PINC) United States $5.196B 17.63
INC Research Holdings (SYNH) United States $4.962B 20.03
HealthEquity (HQY) United States $4.229B 82.67
Teladoc (TDOC) United States $3.750B 0.00
NovoCure (NVCR) Jersey $3.296B 0.00
AMN Healthcare Services Inc (AMN) United States $2.777B 19.06
BioTelemetry (BEAT) United States $2.212B 39.06
Medpace Holdings (MEDP) United States $2.054B 25.41
IKang Healthcare (KANG) China $1.240B 61.55
Intrexon (XON) United States $1.210B 0.00
Healthways (TVTY) United States $1.107B 13.61
CareDx (CDNA) United States $1.067B 0.00
Natera (NTRA) United States $1.051B 0.00
China Cord Blood (CO) China $0.731B 20.03
Surgery Partners (SGRY) United States $0.648B 0.00
Apollo Medical Holdings (AMEH) United States $0.629B 0.00
Establishment Labs Holdings (ESTA) $0.511B 0.00
OncoCyte (OCX) United States $0.063B 0.00
Interpace Diagnostics (IDXG) United States $0.029B 0.00
OpGen (OPGN) United States $0.009B 0.00
Cancer Genetics (CGIX) United States $0.006B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.002B 0.00